Clinical Trials Browser

Phase 1/2 × Hormone Receptor Positive Breast Carcinoma × 1 year × Clear all

NCT04505826 2025-08-24

A Dose Escalation/Expansion Study of Oral OP-1250 in Subjects With Advanced and/or Metastatic HR+, HER2- Breast Cancer

Phase 1/2 Completed

Hormone Receptor Positive Breast Carcinoma